MHC Polymorphism and Tuberculosis Disease by Khalid Sadki et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
14 
MHC Polymorphism and Tuberculosis Disease 
Khalid Sadki, Youssef Bakri, M'Hamed Tijane and Saaid Amzazi 
University Mohammed V-Agdal, Faculty of Sciences,  
Laboratory of Biochemistry and Immunology 
Morocco 
1. Introduction  
Mycobacterium tuberculosis (Mtb), the causal agent of tuberculosis (TB), remains a major 
public health throughout the world causing high mortality in humans. According to the 
report published by the World Health Organization in 2009, 9.3 million new cases of TB 
were declared in the world and 1.3 million HIV-negative people died by this infection 
(http://www.who.int/tb/publications/global_report/2010/en/index.html). One-third of 
the world’s population is estimated to be infected with Mtb, but, only 1 in 10 subjects who 
become infected would develop clinical disease. Furthermore, until now it is not fully 
understood why this category of individuals develop different forms of TB, pulmonary and 
extra pulmonary TB. Several environmental factors principally malnutrition, HIV infection 
and a decrease of socio-economic level favours TB progression. Furthermore, it has been 
confirmed by numerous studies that the outcome of TB infection is under the influence of 
the host genetic background (Vannberg et al., 2011). In fact, twin studies have revealed the 
increased concordance of disease in monozygotic compared with dizygotic twins (Jepson et 
al., 2001; Maartens et al., 2007). In addition, numerous families and case-control studies have 
demonstrated the involvement of many genes in the control of immune response in the 
context of the susceptibility or resistance to TB. Among these genes Major 
Histocompatibility Complex (MHC) takes a substantial and central role in the control of TB 
infection (Kamath et al., 2004).  
MHC is a genetic complex that encodes the antigen-presenting molecules and is involved in 
the recognition and cellular cooperation functions which the substratum is the T lymphocyte. 
Its principal function is to ensure the selection, the transport and the presentation of peptides 
generated in the antigen-presenting cells. MHC is characterized by an extensive 
polymorphism. There are currently 6810 HLA alleles described by the HLA nomenclature and 
integrated in the IMGT/HLA Database (http://www.ebi.ac.uk/imgt/hla/stats.html). This 
particularity allows to this genetic complex a strong impact in term of immune response 
efficiency. While some MHC variant genes play a role in the protection against TB others 
variants in contrast were considered as markers of susceptibility to TB. MHC is the first 
molecule tested for genetic associations with TB susceptibility. For more than four decades, 
several authors have described strong associations between some MHC specificities and 
several immunological disorder including infectious diseases such as TB infection (Yee, 
2004; Hill, 2006). The tri-molecular complex of T cell receptor (TCR), antigenic peptide, and 
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MHC molecules represents the fundamental basis of the immune response. So, genetic 
variation that could occur in any genes which code one of these elements could have an 
impact on the functional levels. MHC system takes a great part of its responsibility in term 
of TB pathogenesis. For example, the impact of MHC class I alleles on the Mtb antigen-
specific CD8+ T-cell response in patients with TB has been reported by several studies 
(weichold et al., 2007; Lewinsohn et al., 2007; Smith & Dockrell, 2000). In addition, according 
to the MHC class I specificity some important specific peptides selected from Mtb antigens 
as Ag85B and 19-kDa lipoprotein are identified to be recognized by CD8 positive T 
lymphocytes (Geluk et al., 2000; Lalvani et al., 1998; Mohagheghpour et al., 1998). These 
CD8 T cells subset has been suggested to control MTB infection.  
The predictive value of MHC system takes a considerable importance concerning 
susceptibility or resistance to TB disease. Two situations are observed: First, certain MHC 
markers are positively associated with disease and thus they are considered as markers of 
susceptibility. Second, other MHC specificities are negatively associated and may have a 
role in the protection against TB. 
In this context, MHC polymorphism has been also employed to identify the efficient peptide 
that can be used to improve sensitivity and specificity of diagnosis test of TB and vaccine 
development. On the basis of the prediction of Mtb antigen sequences that bind to MHC 
molecules, several authors have designed MHC-promiscuous T-cell multi-epitopic peptides 
(Seghrouchni et al., 2009; Zhang et al., 2010).  
The present chapter will discuss the most important work relating, first the impact of MHC 
polymorphism in the outcome of TB infection, and in the second the improvement of 
diagnosis method of TB using reverse immunogenetic.  
2. Major Histocompatibility Complex (MHC) Human Leukocyte Antigen (HLA) 
Major Histocompatibility Complex (MHC) or Human Leukocyte Antigen (HLA) in human 
coding region is located on the short arm of chromosome 6 (6p21.3). It occupies a segment of 
about 4000 kb, containing over 220 identified genes (Robinson J et al., 2003). The strong 
proximity between HLA genes explains why we observe a low rate of genetic recombination 
within this region. Consequently, HLA genes are transmitted as haplotypes from parents to 
children. Each individual inherits two parental haplotypes which expression is codominant. 
The HLA system is divided into three regions (Figure 1) 
- From the centromere, there is HLA class II region (about 900 kb) which includes at least 
32 genes. The most functional histocompatibility genes are represented by HLA-DR, 
HLA-DQ and HLA-DP. Other genes as large multifunctional protease (LMP2 and 
LMP7) or Transporter associated with antigen processing (TAP1 and TAP2) are found 
in this region which play a crucial role, respectively, during antigen processing or in the 
active transport of peptides across the membrane of the endoplasmic reticulum.  
- The intermediate region is HLA class III (about 1100 kb) and is composed of at least 39 
genes. Among them there are tumor necrosis factor (TNF), complement components 
(C4A, C4B, BF, and C2), etc. 
- The telomeric region covers HLA class I genes and spans 1600 kb. This area contains 
about 17 genes and is divided into two sub-classes:   
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HLA classical class I genes (class Ia) namely HLA-A, HLA-B and HLA-C and HLA non-
classical class I (class Ib) namely HLA-E, HLA-F, HLA-G, Major Histocompatibility 
Complex class I chain-related A and B (MICA and MICB), etc. (Figure 1). In this region, 
there is others non histocompatibility genes as UNHCR (-helix coiled coil rod 
homolog),and hemochromatosis gene (HEF). 
HLA class I genes are composed of eight exons and seven introns. Exon 1 encodes the signal 
sequence, exons 2, 3, 4 respectively encode for the extracellular domain ( 1,  2,  3), exon 5 
encodes the transmembrane portion and exons 6, 7, 8 encode the intra-cytoplasmic 
(Malissen et al., 1982). HLA class Ia genes are among the most polymorphic genes described 
in the human genome. According to the IMGT/HLA data base, 1698 alleles of HLA-A, 2271 
alleles of HLA-B and 1213 alleles of HLA-Cw have been identified to date. This genetic 
characterization allows HLA molecule to bind a large repertoire of peptides, controlling T 
cell polarization and consequently the profile of the cytokines production. In contrast, this 
characteristic could subverted if the immune system is disturbed as observed in the auto-
immune and also in some infectious diseases development (De Castro, 2009; Acharya et al., 
2010).  
 
Fig. 1. Genomic organization of Major Histocompatibility Complex region. 
At phenotypic level, HLA class I is represented by two chains: alpha heavy chain (┙) and 
Beta 2-microglobulin (┚2m) light chain, and the interaction between ┙1 and ┙2 domains 
generates a peptide binding cleft (figure 2). HLA class I molecule contains a series of six 
pockets, designated from A to F which can establish different interactions with antigenic 
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peptide residues (Bjorkman et al. 1987; Garrett et al., 1989). The conserved residues in 
pockets A and F are located at each side of the cavity and are responsible for the orientation 
of the binding peptide during antigen presentation step, while polymorphic residues 
located in the pockets B, C, D and E influence the specificity of peptide binding or site of 
peptide conformation within the cavity (Garrett et al., 1989; Madden et al., 1991; Matsumura 
et al., 1992). 
Concerning HLA class II genes, HLA-DRB1 and HLA-DP1 encompass six exons whereas 
HLA-DQB1 includes five exons. HLA-DRB1 is the most polymorphic gene within HLA class 
II. HLA class II molecule consists of two polypeptides chains, alpha (┙) and Beta chain 
(figure 2). Each chain includes two domains ┙1 and ┙2 for alpha chain, and ┚1 and ┚2 for  
┚ chain. The contact established between ┙1 and ┚1 domains creates the peptide binding 
site, which interact with TCR. These two domains play an important role during the 
presentation of antigenic peptide. Moreover, in this region where many genetics variations 
genetic variation are found, which characterize each HLA class II alleles thereby are 
influencing the outcome of the immune response. 
 
Fig. 2. Crystal structure of MHC class I (A) and class II (B) molecules in complex with 
antigenic peptide. (Accession numbers taking from Protein Data Bank are respectively 3PWJ 
and 3L6F) (Borbulevych et al., 2011; Li et al., 2010) (A) : HLA class I is comprised by two 
chains, alpha heavy chain (┙) and Beta 2-microglobulin (┚2m) light chain, with noncovalent 
interaction between them. The peptide binding groove shapes a short cleft by an interaction 
between ┙1 and ┙2 domains. (B): HLA class II molecule consists of two polypeptides chains, 
alpha and Beta chain. Each chain includes two domains ┙1 and ┙2 for alpha chain and ┚1 
and ┚2 for ┚ chain. The interaction between ┙1 and ┚2 domains generates long peptide 
binding clefts which interact with TCR.  
HLA molecules expression is different between the two classes. In fact, HLA class I 
molecules are expressed on most mononuclear cells, whereas class II molecules are 
expressed on antigen presenting cells (APCs): macrophages / monocytes, dendritic cells and 
B cells. Moreover, into the same class, different loci do not have the same level of tissue 
expression, such as HLA-C are naturally more weakly expressed than HLA-A or HLA-B. 
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3. MHC polymorphism and TB disease 
One of the main roles of MHC is to regulate the immune response against all immunological 
abnormalities in normal physiological condition and during infection state. MHC is known 
as one of the important component of susceptibility and resistance to many infectious 
diseases and responsiveness to pathogens or vaccines. In the case of pulmonary TB (PTB) 
disease, case-control association studies have found significant associations between MHC 
genes polymorphism and this pathology (Kettaneh et al., 2006; Yim & Selvaraj, 2010). In fact, 
both genes encoding MHC class I and class II may play crucial roles in host susceptibility to 
PTB. table 1 summarizes the most important immunogenetic association studies related to 
MHC and PTB. Analysis of this table shows that first, the majors susceptibility locus are 
more within MHC class II region compared to those located in MHC class I section. Indeed, 
for MHC class I, almost all genetic association with TB are positive. In contrast, both 
negative and positive association are observed between TB and MHC class II 
polymorphism, suggesting a strong influence of MHC class II in the modulation of the 
immune response to MTB infection through cell-mediated immunity (Moss & Khanna, 1999; 
Kettaneh et al., 2006; Yim & Selvaraj , 2010). 
However, the results are conflicting as reported by several studies. MHC polymorphism 
investigations have revealed, that the allele HLA-DRB1*04 is associated with TB in Syrian 
population (Harfouch-Hammoud & Daher, 2008), HLA-DRB1*07 and HLA-DQA1*0101 in 
Iranians (Amirzargar et al., 2004), HLA-DRB1*11 in Indonesians (Yuliwulandari et al., 2010), 
and HLA-DRB1*1302 in South Africans (Lombard et al., 2006). HLA-DRB1*0803 and HLA-
DQB1*0601 were associated with PTB disease advancement in Koreans while a strong 
association with resistance to recurrent PTB is observed (Kim et al., 2005, Yuliwulandari et 
al., 2010) with HLA-DRB1*12 in Indonesians (Yuliwulandari et al., 2010). Finally, HLA-DR2 
seems to be the main allele positively associated with PTB. This observation is replicated in 
populations with different genetic background, Indian (Brahmajothi et al., 1991, Ravikumar 
et al., 1999, Sriram et al., 2001), Chinese (Shi et al., 2011) and polish (Dubaniewicz et al., 
2000). HLA-DR2 is divided into two subtypes, DRB1*15 and DRB*16. Except for the study 
reported by Dubaniewicz and his colleagues, DRB1*15, especially the DRB1*1501 allele, is 
strongly associated with PTB susceptibility (Dubaniewicz et al., 2000). This observation 
suggests that amino acids present in DR15 molecule but absent in DR16 could play an 
important role in the development of PTB. Certainly, this data does not exclude the 
involvement of other region parts of the protein and/or other immunoregulatory linked 
genes. The nucleotide sequence of the peptide presented by DRB1*15 are so different from 
those presented by DRB1*16 and may be recognized by CD4+ T lymphocytes as inadequate 
form and consequently this situation could disturb the effective immune anti-TB response. 
At functional level, it has been suggested that HLA-DRB1*1501 and HLA-DRB1*1502 may 
be associated with down-regulation of perforin-positive cytotoxic cells (T-lymphocytes and 
natural killer) in PTB, supporting the potential role of theses alleles in the TB susceptibility 
(Rajeswari et al., 2007). On the other hand, HLA-DRB1*16 but not HLA-DRB1*15 are 
observed more frequently in Brazilian leprosy patients than in controls group (9.0% vs. 1.8%; 
P = 0.0016; OR = 5.81; CI = 2.05–16.46), underlying a difference in the impact of MHC 
polymorphism which may be related to the specificity of each pathology (Da silva et al., 
2009).  
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Candidate allele Genetic polymorphisms 
association 
Population
P-value OR 
References 
Positive Negative
Recurrent 
disease 
HLA class I          
A1 
 X  Indian <0.001 ND 
(Balamurugan  
et al., 2004)  
B*1802 
  X Indonesian 0,013 ND 
(Yuliwulandari  
et al., 2010) 
B*4001  
  X Indonesian 0,015 ND 
(Yuliwulandari 
et al., 2010) 
B51 
X   Indian <0.0001 0.0 
(Vijaya Lakshm  
et al., 2006) 
B52 
 X  Indian <0.0001 18.53
(Vijaya Lakshm  
et al., 2006) 
Cw6 
 X  Indian <0.001 ND 
(Balamurugan  
et al., 2004) 
Cw7 
X   Indian <0.001 ND 
(Balamurugan  
et al., 2004) 
HLA class II          
DR2 
X   Indian 0,01 0.29 
(Brahmajothi 
et al., 1991) 
DRB1*1501 
X   Indian 0.013 2.68 
(Ravi kumar  
et al., 1999) 
DRB1*15 X   Chinese 0,001 3.79 (Shi et al., 2011) 
DRB1*16  
X   Polish <0.01 9.7 
(Dubaniewicz  
et al., 2000) 
DQB1*0301-*0304 
x   
South 
Africa 
0,001 2.58 
(Lombard  
et al., 2006) 
DRB1*04  
X   Syrian  0,01 1.77 
(Harfouch-Hammoud 
& Daher, 2008) 
DRB1*11   
 X  Syrian  0,003 0.51 
(Harfouch-Hammoud 
& Daher, 2008) 
DRB1*1101 
  X Indonesia. 0,008 ND 
(Yuliwulandari  
et al., 2010) 
DRB1*1202  
  X Indonesia. 0.0008 0.32 
(Yuliwulandari  
et al., 2010) 
DRB1*13   
 X  Polish <0.001 0.04 
(Dubaniewicz  
et al., 2000) 
DRB1*1302  
X   
South 
Africa 
<0,001 5.05 
(Lombard  
et al., 2006) 
DRB1*07  
X   Iranian 0.025 2.7 
(Amirzargar  
et al., 2004) 
DRB1*0803  
  X Korean 0.00009 5.31 
(Kim  
et al., 2005) 
DQA1*0301  
 X  Iranian 0.033 0.25 
(Amirzargar  
et al., 2004) 
DQA1*0601  
 X  Thailandaise 0.02 ND 
(Vejbaesya  
et al., 2002) 
DQB1*0301 
 X  Thailandaise 0.01 ND 
(Vejbaesya  
et al., 2002) 
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Candidate allele Genetic polymorphisms 
association 
Population
P-value OR 
References 
Positive Negative
Recurrent 
disease 
DQB1*0502 
X   Thailandaise 0.01 2.06 
(Vejbaesya  
et al., 2002) 
DQB1*0601 
X   Indian 0.008 2.32 
(Ravi kumar  
et al., 1999) 
  X Korean 0.00003 5.45 
(Kim  
et al., 2005) 
Table 1. Genetic associations of important MHC gene variants with the susceptibility or 
resistance to tuberculosis and with disease recurrence. (OR: Odds ratio, ND: no Data) 
Additionally, certain alleles like DRB1*11 and DRB1*13 are in contrast associated with 
protection against PTB (Harfouch-Hammoud & Daher 2008; Dubaniewicz et al., 2000). This 
conflicting results reported in theses studies could be due to the positive linkage 
disequilibrium (LD) observed between MHC class II alleles. DRB1*11-DQB1*03 haplotype 
was found in positive LD in controls polish patients (Dubaniewicz et al., 2005). In this case, 
DRB1*03 itself but not DRB1*11 may be linked to the resistance to TB. The hypothesis of the 
presence of other alleles in LD with DRB1*11-DQB1*03 haplotype is not excluded.  
However, even if there are few studies reported in the literature concerning the impact of 
MHC class I polymorphism on the TB development, it seems likely that some MHC class I 
alleles are associated with PTB disease, as HLA-A1, HLA-B51, HLA-Cw6 and HLA-Cw7 in 
Indians (Balamurugan et al., 2004; Vijaya Lakshmi et al., 2006) and HLA-B*1802 and HLA-
B*4001 in Indonesians (Yuliwulandari et al., 2010). Analysis of these results and others 
showed that HLA-B alleles may play the main role in PTB development comparing to the 
other alleles of MHC class I. HLA-B gene is the most polymorphic gene within the human 
MHC and the fundamental genetic variation occurs within exon 2 and exon 3, known by its 
determinant function during the presentation of antigenic peptide step. As cited above 2271 
alleles of HLA-B are identified to date. In recent cellular immunological study, using IFN-g 
ELISPOT and following stimulation of T cell clones with specific Mtb synthetic peptide 
arrays, Lewinsohn and his colleagues have demonstrated that the immunodominant TB 
CD8 antigens was preferentially restricted by HLA-B (Lewinsohn et al., 2007). In the same 
way, it has been reported that the majority of epitope-specific CD8 T cells are HLA-B alleles 
restricted in patients with PTB and in addition these alleles found fast off-rates in peptide 
binding (Weichold et al., 2007). 
4. Reverse Immunogenetic and TB diagnosis test development 
For several years biologists used direct smear microscopy and culture for active TB 
diagnosis. But, until now the gold standard test remains the culture isolation of Mtb and it is 
the only test that confirms the diagnosis of TB disease. The control of the disease depends 
absolutely on early identification and treatment of active cases. However, direct microscopic 
examination as well as the culture doesn’t have an adequate sensitivity and specificity, 20% 
and 80% for the first test and 60% and 99% for the second. For this reason, many teams 
interested in this topic have tried to improve these two parameters in bacteriological, 
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immunological and molecular biology techniques. At immunological levels, numerous 
studies have been reported on the cellular and humoral immunology field a significant 
improvement for the diagnosis of TB have been described (Seghrouchni et al., 2009; 
Panigada et al., 2002, Zhang et al., 2010). Unfortunately, none of the immunological methods 
reported in these studies was able to discriminate between active TB and latent TB infection. 
The use of Elispot technique and also the specific Mtb antigen have certainly played a good 
progress to resolve this problem. Among the panel of immunological technology used and 
the most relevant approach applied in this context is the reverse immunogenetic technique, 
based on in-silico identification peptide. This method allows the scientific community to 
better investigate the antigenic peptides that are presented by the relevant MHC molecules. 
Furthermore, this strategy offers the possibility to identify the specific T lymphocyte 
epitopes from living cells and provides a precious help for the development of vaccine 
candidates. This approach has been elegantly used to identify a specific T lymphocyte 
epitopes antigen in cancer (Liu et al., 2011; Imai et al., 2011) and in infectious disease 
(Kawashima et al., 2008; Hossain et al., 2003; Sobao et al., 2001; Seghrouchni et al., 2009; 
Wang et al., 2010). Various studies have been reported regarding the use of this strategy in 
TB disease. All immunological investigations are focused to produce a specific and synthetic 
peptide of Mtb in order to improve the sensitivity and the specificity of the diagnosis Kits. 
Several MTB-specific antigenic peptides demonstrated their potential application for TB 
diagnosis, (Ravn et al., 1999; Arend et al., 2002, Seghrouchni et al., 2009; Panigada et al., 
2002, Zhang et al., 2010).  
Both MHC class I and class II-restricted responses against Mtb are explored in this context 
with major importance for MHC class II. This importance takes its consideration regarding 
the roles played by CD4 T Lymphocytes in developing candidate vaccine for TB. In fact, 
Numerous Mtb specific antigens for CD4+ T lymphocytes have been identified and 
characterized up till now. We have previously identified Mtb specific peptide, selected from 
RD1 genomic region (Mahairas et al., 1996) and from proteins expressed during MTB 
growth in human macrophage (Cappelli et al., 2006; Mariani et al., 2000), and which are 
predicted to bind HLA–DR alleles (Seghrouchni et al., 2009. Baassi et al., 2009). IFN-┛ 
ELISPOT after stimulation by Mtb selected peptide of peripheral blood mononuclear cells, 
extracted from TB patients and Healthy controls, have revealed an excellent result. In fact, 
using statistical algorithms we have identified a pool of specific Mtb immunodominant B 
and T cell epitopes, able to discriminate between active TB patients, tuberculin skin test 
positive (Mtb exposed subjects) and tuberculin skin test negative controls. A similar study 
has been reported recently using bioinformatic tools (chaitra et al., 2008). In fact, the authors 
of this work have designed some HLA class I binding epitopes of the PE (Pro-Glu) and PPE 
(Pro-Pro-Glu) proteins of Mtb, which are coded by Rv1818c, Rv3812 and Rv3018c genes, and 
have observed a significant difference in the responsiveness between healthy subjects and 
TB patients. 
Likewise, other investigations have been reported concerning MHC class I and in-silico 
identification peptides. By means of appropriate bioinformatic tools several peptides are 
identified and could be used to improve both TB diagnosis and vaccine development. More 
recently, using HLA-peptide tetramers derived from Mtb peptides predicted to bind to 
HLA-A*0201, Tang and his colleagues have found a very interesting Mtb epitopes activating 
polyfunctional CD8+ T cells in human TB (Tang et al., 2011). Moreover, some specific 
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peptides to CD8 T Lymphocytes as HLA-B*35-restricted CD8(+) T-cell epitope in Mtb 
Rv2903c (Klein et al., 2002), HLA-A*0201-restricted T-cell epitope in the MPT51 protein 
(Aoshi et al., 2008) and HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 (aa 204-
212) WPTLIGLAM (Klein et al., 2001), were demonstrated to have a potential positive effect 
on Mtb -infected macrophages and produce significant level of gamma interferon and tumor 
necrosis factor alpha.  
5. Conclusion 
Taking all these data together reported in this review we can conclude that: MHC 
polymorphism and immunogenetic reverse studies offer a precious help at different level, in 
the identification of susceptibility/resistance genes or cluster of genes that are involved in 
the TB disease, and in the characterisation of a specific and relevant Mtb T lymphocyte 
epitopes for diagnosis improvement and vaccine development. The advancement of 
bioinformatic tools and immunological technologies could undoubtedly contribute to 
understand well the immunogenetic of TB, and consequently to improve the quality and the 
reliability (sensitivity/specificity) of immunological diagnosis Kits. 
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